Background: Sickle cell disease (SCD) is among the most frequent hereditary disorders
globally and its prevalence in Europe is increasing due to migration movements. Summary …

Abstract Background and Objective Treatment of sickle cell disease (SCD) has traditionally
focused on symptomatic and preventative care. Recent advances in novel therapeutic …

Background: Sickle cell anemia (SCD) is a relatively uncommon health condition in many
countries, but it is prevalent in Saudi Arabia mainly due to the high incidence of …

Emerging technology in laboratory medicine can be defined as an analytical method
(including biomarkers) or device (software, applications, and algorithms) that by its stage of …

The acute pain crisis (APC) is the commonest complication of sickle cell disease (SCD).
Severe episodes may require treatment in hospital with strong opioid analgesic drugs …

REHem-AR was created in 2013. The progressive implementation of neonatal screening for
haemoglobinopathies in Spanish autonomous communities where the registry had not been …

In this short review we have presented and discussed studies on pharmacogenomics (also
termed pharmacogenetics) of the drugs employed in the treatment of β-thalassemia or Sickle …

We aimed to provide evidence on the trends and in-hospital outcomes of patients with low-
and high-flow priapism through the largest study in the field. We used the GeRmAn …

In 2015, Catalonia introduced sickle cell disease (SCD) screening in its newborn screening
(NBS) program along with standard-of-care treatments like penicillin, hydroxyurea, and anti …

Background Ensuring equitable access to adequate standard of care for patients with rare
hematological disease is one of the aims of the European Reference Network (ERN) …